Senior insider sale
CEO and Chairman at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$14.80M
600K shares
What this filing means
ROBINS CHAD M plans to sell 600K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $14.80M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001958244-26-000527
DirectorOfficer· CEO and Chairman
Since Jun 2019
600K
Shares to sell
$14.80M
Approx. market value
278.68K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
2/7/2018
278.68KTotal acquired278.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/7/2018 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 278.68K | — |
| Total | 278.68K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
321.32K
Market value
$7.96M
8/17/2026
Planned — Approximate Date
NASDPlanned
Units to sell
278.68K
Market value
$6.84M
8/18/2026
Total
Units
600K
Value
$14.80M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/17/2026 | 321.32K | $7.96M | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 278.68K | $6.84M | NASD | Planned |
| Total | 600K | $14.80M | ||